Zbtb42, a zinc finger and BTB domain-containing protein, plays a pivotal role in cellular processes through its distinctive functions as a DNA-binding transcription factor. Specifically, it exhibits RNA polymerase II-specific and cis-regulatory region sequence-specific DNA binding activities, positioning it as a key regulator of gene expression. The protein is situated in both the cytoplasm and nucleoplasm, underscoring its versatile role in intracellular processes. Zbtb42's ortholog in humans is implicated in lethal congenital contracture syndrome, emphasizing its significance in developmental pathways. Activation of Zbtb42 involves a nuanced orchestration of cellular signaling pathways, influenced by various chemical entities. These pathways intricately modulate Zbtb42's transcriptional activity, contributing to its up-regulation and functional enhancement. The mechanisms of activation include the inhibition of negative regulators and the modulation of key signaling cascades. For instance, chemicals like curcumin enhance Zbtb42 by inhibiting NF-κB signaling, disrupting its negative influence on Zbtb42 and promoting its transcriptional activity. Similarly, other chemicals act through pathways such as PI3K/Akt, SIRT1/AMPK, and JNK, among others, illustrating the diverse regulatory landscape governing Zbtb42 activation.
The comprehensive understanding of these mechanisms sheds light on the intricate web of interactions that govern Zbtb42's function. The protein emerges as a crucial player in cellular processes, and its activation is finely tuned by various chemicals targeting specific signaling pathways. This intricate interplay highlights the dynamic nature of Zbtb42 regulation and its significance in modulating gene expression patterns. Further exploration of the specific biochemical and cellular contexts in which these activations occur will deepen our understanding of Zbtb42's role in cellular physiology and potentially unveil novel avenues for targeted modulation in a research context.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin enhances Zbtb42 activation by inhibiting NF-κB signaling. It suppresses the activity of IKK, preventing IκB degradation and subsequently promoting Zbtb42 transcriptional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates Zbtb42 indirectly by modulating the SIRT1/AMPK pathway. It stimulates SIRT1, leading to deacetylation of key regulators, ultimately promoting Zbtb42 function. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin up-regulates Zbtb42 through inhibition of PI3K/Akt signaling. By suppressing Akt phosphorylation, it disrupts the inhibitory influence on Zbtb42, thereby promoting its activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane indirectly activates Zbtb42 by modulating the Nrf2/ARE pathway. It induces Nrf2, leading to the transcriptional up-regulation of Zbtb42, promoting its function in cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 triggers Zbtb42 activation by inhibiting p38 MAPK signaling. Inhibition of p38 MAPK prevents its negative regulation on Zbtb42, thereby enhancing its transcriptional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 stimulates Zbtb42 indirectly by inhibiting PI3K signaling. Inhibition of PI3K disrupts the negative regulation on Zbtb42, promoting its activity and involvement in cellular processes. | ||||||
JNK Inhibitor VIII | 894804-07-0 | sc-202673 | 5 mg | $267.00 | 2 | |
JNK Inhibitor VIII promotes Zbtb42 by inhibiting JNK signaling. Suppression of JNK prevents its inhibitory effect on Zbtb42, leading to enhanced transcriptional activity and functional up-regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin up-regulates Zbtb42 by inhibiting PI3K signaling. Suppression of PI3K disrupts the negative regulation on Zbtb42, promoting its activity and involvement in cellular processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein enhances Zbtb42 activation by inhibiting ERK signaling. Inhibition of ERK prevents its inhibitory effect on Zbtb42, leading to increased transcriptional activity and functional up-regulation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A769662 activates Zbtb42 indirectly by modulating the AMPK pathway. It activates AMPK, leading to downstream effects that promote Zbtb42 function, contributing to cellular processes. | ||||||